Access HCV Ab V3 QC - Hepatitis C virus total antibody IVD, control
Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Public Assessment Report
(PAR)
22-11-2017
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Available from:
Bio-Rad Laboratories Pty Ltd
Class:
Class 4
Manufactured by:
Bio-Rad 3 Boulevard Raymond Poincare, 92430 MARNES-LA-COQUETTE France
Therapeutic area:
41973 - Hepatitis C virus total antibody IVD, control
Therapeutic indications:
For monitoring the system performance of the Access HCV Ab V3 assay. For monitoring the system performance of the Access HCV V3 assay.
Authorization status:
A
Authorization date:
2017-05-11
